Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Willand

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Medicinal Chemistry|June 12, 2022
Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administrationKevin Antraygues, Mathieu Maingot, Birgit Schellhorn, et al.
The Journal of Biological Chemistry|June 2, 2024
Small molecule MarR modulators potentiate metronidazole antibiotic activity in aerobic E. coli by inducing activation by the nitroreductase NfsAThibault Caradec, Coline Plé, Giuseppe Sicoli, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthRAbdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
British Journal of Clinical Pharmacology|April 17, 2024
Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacinDiana A Aguilar-Ayala, Fernando Sanz-García, Marie Sylvianne Rabodoarivelo, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9-10 December 2021Kevin Antraygues, Nina Compagne, Francesca Ruggieri, et al.
Iscience|April 6, 2026
An assay toolkit for anti-tuberculosis drugs in the hollow fiber systemFernando Sanz-García, Dominique Ndjogou, Diana A Aguilar-Ayala, et al.
European Journal of Medicinal Chemistry|July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pumpNina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
Applied Microbiology and Biotechnology|June 30, 2021
Rubrolone production by Dactylosporangium vinaceum: biosynthesis, modulation and possible biological functionSophie Moureu, Thibault Caradec, Xavier Trivelli, et al.
European Journal of Medicinal Chemistry|February 21, 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2Hugues Prevet, Martin Moune, Abdalkarim Tanina, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Medicinal Chemistry|June 12, 2022
Design and synthesis of water-soluble prodrugs of rifabutin for intraveneous administrationKevin Antraygues, Mathieu Maingot, Birgit Schellhorn, et al.
The Journal of Biological Chemistry|June 2, 2024
Small molecule MarR modulators potentiate metronidazole antibiotic activity in aerobic E. coli by inducing activation by the nitroreductase NfsAThibault Caradec, Coline Plé, Giuseppe Sicoli, et al.
Analytical Biochemistry|February 25, 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligandsCéline Crauste, Nicolas Willand, Baptiste Villemagne, et al.
Biochimica Et Biophysica Acta. Proteins and Proteomics|December 17, 2018
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthRAbdalkarim Tanina, Alexandre Wohlkönig, Sameh H Soror, et al.
British Journal of Clinical Pharmacology|April 17, 2024
Evaluation of critical parameters in the hollow-fibre system for tuberculosis: A case study of moxifloxacinDiana A Aguilar-Ayala, Fernando Sanz-García, Marie Sylvianne Rabodoarivelo, et al.
Pharmaceuticals (Basel, Switzerland)|April 23, 2022
On the Hunt for Next-Generation Antimicrobial Agents: An Online Symposium Organized Jointly by the French Society for Medicinal Chemistry (Société de Chimie Thérapeutique) and the French Microbiology Society (Société Française de Microbiologie) on 9-10 December 2021Kevin Antraygues, Nina Compagne, Francesca Ruggieri, et al.
Iscience|April 6, 2026
An assay toolkit for anti-tuberculosis drugs in the hollow fiber systemFernando Sanz-García, Dominique Ndjogou, Diana A Aguilar-Ayala, et al.
European Journal of Medicinal Chemistry|July 17, 2023
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pumpNina Compagne, Juan-Carlos Jiménez-Castellanos, Virginie Meurillon, et al.
Applied Microbiology and Biotechnology|June 30, 2021
Rubrolone production by Dactylosporangium vinaceum: biosynthesis, modulation and possible biological functionSophie Moureu, Thibault Caradec, Xavier Trivelli, et al.
European Journal of Medicinal Chemistry|February 21, 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2Hugues Prevet, Martin Moune, Abdalkarim Tanina, et al.
Pageof 5